Hematopoietic Progenitor Kinase1 (HPK1) Mediates T Cell Dysfunction and Is a Druggable Target for T Cell-Based Immunotherapies

Cited by (214)

Items 201–214 of 214

  1. BindingDB Entry 50021897: Discovery of an Exceptionally Orally Bioavailable and Potent HPK1 PROTAC with Enhancement of Antitumor Efficacy of Anti-PD-L1 Therapy.
    BindingDB · 2025 · UC San Diego
  2. BindingDB Entry 50020901: Discovery of 5-aminopyrido[2,3-d]pyrimidin-7(8H)-one derivatives as new hematopoietic progenitor kinase 1 (HPK1) inhibitors.
    BindingDB · 2025 · UC San Diego
  3. BindingDB Entry 50022994: Discovery of Novel PROTAC-Based HPK1 Degraders with High Potency and Selectivity for Cancer Immunotherapy.
    BindingDB · 2026 · UC San Diego
  4. BindingDB Entry 50013789: Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool Compounds.
    BindingDB · 2022 · UC San Diego
  5. BindingDB Entry 50020545: Design, Synthesis, and Pharmacological Evaluation of Isoindoline Analogues as New HPK1 Inhibitors.
    BindingDB · 2024 · UC San Diego
  6. BindingDB Entry 50022957: Discovery of 1(2H)-phthalazinone and 1(2H)-isoquinolinone derivatives as potent hematopoietic progenitor kinase 1 (HPK1) inhibitors.
    BindingDB · 2026 · UC San Diego
  7. BindingDB Entry 50012716: Identification of Potent Reverse Indazole Inhibitors for HPK1.
    BindingDB · 2022 · UC San Diego
  8. BindingDB Entry 50019356: Discovery of 7H-Pyrrolo[2,3-d]pyrimidine Derivatives as potent hematopoietic progenitor kinase 1 (HPK1) inhibitors.
    BindingDB · 2024 · UC San Diego
  9. BindingDB Entry 50019406: Discovery of quinazoline HPK1 inhibitors with high cellular potency.
    BindingDB · 2024 · UC San Diego
  10. BindingDB Entry 50023115: Design, Synthesis, and biological evaluation of 7H-Pyrrolo[2,3-d]pyrimidines as potent HPK1 kinase inhibitors.
    BindingDB · 2026 · UC San Diego
  11. BindingDB Entry 50023752: Structure-Guided Optimization of 2-Aminoquinazoline Hematopoietic Progenitor Kinase 1 Inhibitors for Improved Oral Bioavailability and Synergistic Antitumor Immunity.
    BindingDB · 2026 · UC San Diego
  12. BindingDB Entry 50022713: Discovery of Pyridine-2-Carboxamides Derivatives as Potent and Selective HPK1 Inhibitors for the Treatment of Cancer.
    BindingDB · 2026 · UC San Diego
  13. BindingDB Entry 50018195: Potent and Selective Biaryl Amide Inhibitors of Hematopoietic Progenitor Kinase 1 (HPK1).
    BindingDB · 2024 · UC San Diego
  14. Discovery of a Novel Pyrido[2,1- h ]pteridin-6-one Derivative as a Potent and Orally Bioavailable HPK1 Inhibitor
    Yun Wu, Chenliang Shi, Chao Wu, Ziping Qi, Rui Jin, Qingwang Liu, Qianmao Liang, Aoli Wang, Wenchao Wang, Beilei Wang et al. · 2026 · Journal of Medicinal Chemistry